MHI Funds’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
MHI Funds's PFE Position: Q1 2020 in Review
MHI Funds reduced its Pfizer (PFE) stake by 36% in Q1 2020, selling an estimated $533K and leaving 27,625 shares worth $855K. The position accounts for 2.46% of the portfolio, ranked #22.
MHI Funds first reported a position in PFE in Q4 2017 and has held it in 10 quarters since. The position peaked at $4.11M in Q3 2018. 2,438 funds tracked by Wall St. Rank hold PFE as of Q1 2020.
- MHI Funds held 27,625 shares of Pfizer worth $855K as of Q1 2020.
- MHI Funds sold 15,650 Pfizer shares in Q1 2020, an estimated $533K.
- Pfizer made up 2.46% of MHI Funds's portfolio in Q1 2020, its #22 holding.
- MHI Funds first reported a position in Pfizer in Q4 2017 and has held it in 10 quarters since.
- MHI Funds's Pfizer position peaked at $4.11M in Q3 2018.
- 2,438 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.
Based on MHI Funds's 13F filing for Q1 2020, filed 5 May 2020.